| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Laxai is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedClean Technologies is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bionostics Inc is a Devens, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cardinal Analytx Solutions brings together distinguished innovators and leaders collaboratively advancing into new territory to substantially address one of the most pressing human and economic challenges of our time.